#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Immune-mediated myositis Glioblastoma Cluster headache Alport's syndrome Immunoglobulin G4 related disease Anal cancer Metastases to central nervous system Dementia Anti-HLA antibody test positive Metastases to peritoneum Autoimmune hepatitis Scedosporium infection Cutaneous T-cell lymphoma stage II Non-Hodgkin's lymphoma refractory Anaemia More trials…

    Learn about Rare Diseases

    Behcet’s syndrome – Treatment Adrenogenital syndrome – Treatment X-linked lymphoproliferative syndrome – Trials in Disease Congenital hypotransferrinaemia – Treatment Biotinidase deficiency Atypical teratoid/rhabdoid tumour of CNS Nephrotic syndrome – Trials in Disease Marginal zone lymphoma – Trials in Disease Uterine leiomyosarcoma – Trials in Disease Wiskott-Aldrich syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    OMTX705 Lenzumestrocel Indometacin Ph. Eur. Doxorubicin Hydrochloride Vutrisiran Bi 3720931 Paltusotine ZILEBESIRAN Paraffin White Soft Levomepromazine Hydrochloride Metronidazole Rbd4059 TEV-53408 AVTX-009 Damoctocog Alfa Pegol Danicamtiv Lib-01 Monohydrate Jnj-77242113 Zetomipzomib Naproxen More therapies…

    Learn about Your Condition

    Poor quality sleep Pelizaeus-Merzbacher disease Toxicity to various agents Raynaud's phenomenon Diabetic gastroparesis Cutibacterium acnes infection Mixed-type liposarcoma Stress cardiomyopathy Bartonellosis Indolent systemic mastocytosis Pneumonia chlamydial Synovial sarcoma Endometrial cancer stage IV Pain in extremity Klinefelter's syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Hospitalier Universitaire De La Reunion

Centre Hospitalier Universitaire De La Reunion

Allee Des Topazes, Cs 11021, St Denis, 97400, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Tioguanine and Drug Combination for Patients Aged 0-45 with Newly Diagnosed Acute Lymphoblastic Leukemia

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Acute lymphocytic leukaemia
    Investigated Drugs:
    • Hydrocortisone Sodium Phosphate
    • Hydrocortisone Sodium Succinate
    • Inotuzumab Ozogamicin
    Belgium Denmark Estonia Finland France Germany +8

  • Evaluation of Anifrolumab Subcutaneous Treatment in Immunosuppressant‑Naïve and Biologic‑Naïve Patients with Systemic Lupus Erythematosus

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Anifrolumab
    France Germany Italy Poland Spain

  • Three‑Day versus Seven‑Day Antibiotic Treatment with doxycycline, amoxicillin and ceftriaxone in adults with mild leptospirosis

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Doxycycline Hyclate
    • Ceftriaxone
    • Doxycycline
    France

  • Obinutuzumab in patients with pure class V lupus nephritis (systemic lupus erythematosus membranous nephropathy) – phase II trial

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Obinutuzumab
    France

  • Study of drug combination with radiotherapy versus radiotherapy alone for locally advanced rectal cancer in patients 75 years and older

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Rectal adenocarcinoma
    Investigated Drugs:
    • Calcium Levofolinate
    • Fluorouracil
    • Folinic Acid
    France

  • Comparison of compression therapy alone versus compression therapy with phenoxymethylpenicillin for preventing recurrent erysipelas in lower limbs

    Not yet recruiting

    3 1 1 1
    France

  • Study on Multiple Myeloma Treatment with Isatuximab, Lenalidomide, and Carfilzomib for Patients Under 66 Eligible for Stem Cell Transplant

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Iberdomide
    • Carfilzomib
    • Dexamethasone
    Belgium France

  • Study on the Effectiveness of Carboplatin and Paclitaxel in Treating Cervical Cancer with Para-aortic Lymph Node Involvement

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Cervix carcinoma stage III
    • Cervix carcinoma stage IV
    • Cervix carcinoma
    Investigated Drugs:
    • Carboplatin
    • Paclitaxel
    France

  • Study on the Use of PET Scans with Fludeoxyglucose (18F) for Diagnosing Endometriosis in Patients with Symptoms

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Endometriosis
    Investigated Drugs:
    • Furosemide
    • Fludeoxyglucose (18F)
    • Iohexol
    France

  • Study on Reducing Treatment Intensity for Patients with HPV-Positive Oropharyngeal Cancer Using Cisplatin and Carboplatin

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Oropharyngeal squamous cell carcinoma
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    France Germany
Previous Page
1 2 3 4 5 6 7
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!